A detailed history of Ikarian Capital, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Ikarian Capital, LLC holds 202,100 shares of SRRK stock, worth $8.66 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
202,100
Previous 183,701 10.02%
Holding current value
$8.66 Million
Previous $1.53 Million 5.75%
% of portfolio
0.28%
Previous 0.62%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.84 - $16.79 $846,720 - $1.81 Million
-108,000 Reduced 37.02%
183,701 $1.53 Million
Q1 2024

May 15, 2024

BUY
$13.2 - $17.76 $3.85 Million - $5.18 Million
291,701 New
291,701 $5.18 Million
Q2 2021

Aug 16, 2021

SELL
$26.34 - $46.62 $1.77 Million - $3.13 Million
-67,059 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$45.96 - $68.02 $2.3 Million - $3.4 Million
-50,000 Reduced 42.71%
67,059 $3.4 Million
Q4 2020

Feb 12, 2021

BUY
$13.72 - $51.57 $1.61 Million - $6.04 Million
117,059 New
117,059 $5.68 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.21B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.